
Opinion|Videos|August 8, 2024
Evolving Goals in Rheumatoid Arthritis Treatment: Defining and Achieving Clinical Remission
A panel of medical experts discuss how clinical guidelines currently define clinical remission, as well as the clinical and economic benefits associated with clinical remission.
Advertisement
Episodes in this series

Over the past few years, the goal of rheumatoid arthritis treatment has evolved from relieving symptoms to achieving clinical remission, which inhibits radiologic damage and prevents disability.
1. How do clinical guidelines currently define clinical remission?
2. What are the clinical and economic benefits associated with clinical remission?
Advertisement
Related to this article

Amplio Pharma now planning a phase 2a study after NovoBioJect raised intracellular active methotrexate levels by 38%.

The EC approved upadacitinib for active polyarticular JIA in children 2 years and older, based on phase 1 SELECT-YOUTH efficacy and safety data.
Advertisement
Advertisement
Trending on Rheumatology Live
1
Nipocalimab, Telitacicept, and the Sjögren’s Disease Pipeline
2
Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD
3
Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD
4
INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH
5

